These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 176391)

  • 1. Workshop on Epstein-Barr virus: summary and recommendations.
    Ablashi DV; Aaslestad HG; de-Thé G
    J Natl Cancer Inst; 1976 Feb; 56(2):451. PubMed ID: 176391
    [No Abstract]   [Full Text] [Related]  

  • 2. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.
    Piriou E; van Dort K; Otto S; van Oers MH; van Baarle D
    Clin Infect Dis; 2008 Jan; 46(2):313-6. PubMed ID: 18171268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Epstein-Barr virus a human tumor virus?
    Gerber P
    Natl Cancer Inst Monogr; 1973 May; 36():65-71. PubMed ID: 4355351
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitory effect of adult bovine serum on release of infectious Epstein-Barr virus from a virus-carrier cell line.
    Sairenji T; Hinuma Y
    J Natl Cancer Inst; 1975 Aug; 55(2):339-43. PubMed ID: 169373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental infection of Callithrix Jacchus marmosets with Herpesvirus ateles, Herpesvirus saimiri, and Epstein Barr virus.
    Ablashi DV; Pearson G; Rabin H; Armstrong G; Easton J; Valerio M; Cicmanec J
    Biomedicine; 1978 Feb; 29(1):7-10. PubMed ID: 208678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Epstein-Barr virus antigens in human lymphoblastoid P3HR-1 cells with culture fluid of Fusobacterium nucleatum.
    Ito Y; Kishishita M; Yanase S
    Cancer Res; 1980 Nov; 40(11):4329-30. PubMed ID: 6258779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
    Miller G; Lipman M
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):190-4. PubMed ID: 4346033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibitory effects of retinoic acid on Epstein-Barr virus induction in producer and nonproducer cell lines.
    Morigaki T; Sugawara K; Ito Y
    Intervirology; 1984; 22(1):56-60. PubMed ID: 6329997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of infective Epstein-Barr virus in a Burkitt lymphoma cell line, P3HR-1.
    Nagoya T; Hinuma Y
    Gan; 1972 Feb; 63(1):87-93. PubMed ID: 4339714
    [No Abstract]   [Full Text] [Related]  

  • 10. Modes of Epstein-Barr virus infection in human floating cell lines.
    Sairenji T; Hinuma Y
    Gan; 1973 Dec; 64(6):583-90. PubMed ID: 4360583
    [No Abstract]   [Full Text] [Related]  

  • 11. Epstein-Barr virus.
    Jenson HB
    Pediatr Rev; 2011 Sep; 32(9):375-83; quiz 384. PubMed ID: 21885661
    [No Abstract]   [Full Text] [Related]  

  • 12. Superinfection epithelial nasopharyngeal carcinoma cells with Epstein-Barr virus.
    Glaser R; de Thé G; Lenoir G; Ho JH
    Proc Natl Acad Sci U S A; 1976 Mar; 73(3):960-3. PubMed ID: 176664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of efficiency of various methods of induction of Epstein-Barr virus antigens synthesis in human lymphoblastoid cell lines].
    Prachová K
    Cesk Epidemiol Mikrobiol Imunol; 1982 Jul; 31(4):236-41. PubMed ID: 6288272
    [No Abstract]   [Full Text] [Related]  

  • 14. The relation of the Epstein-Barr virus to Burkitt's lymphoma.
    Henle W; Henle G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):40-6. PubMed ID: 4145613
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma.
    Mazurenko NP; Gurtsevich VE; Stepina VN; Plakhov IV
    Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138
    [No Abstract]   [Full Text] [Related]  

  • 16. [Epstein-Barr virus and human cells: transforming and cell-killing infections (author's transl)].
    Mizuno F
    Hokkaido Igaku Zasshi; 1978 Nov; 53(6):489-95. PubMed ID: 230999
    [No Abstract]   [Full Text] [Related]  

  • 17. Simple assay method for susceptibility of human lymphocytes to Epstein-Barr virus infection.
    Takada K; Osato T
    Intervirology; 1982; 18(1-2):87-91. PubMed ID: 6288618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus: The Path from Latent to Productive Infection.
    Chiu YF; Sugden B
    Annu Rev Virol; 2016 Sep; 3(1):359-372. PubMed ID: 27578440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epstein-Barr virus and human lymphoproliferative disorders.
    Schnipper LE
    Prog Hematol; 1981; 12():275-97. PubMed ID: 6280236
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of Epstein-Barr virus-induced membrane antigens in lymphoid cells to viral envelope antigens.
    Gerber P; Goldstein G
    J Immunol; 1970 Sep; 105(3):793-5. PubMed ID: 4318485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.